Tekmira Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Tekmira Pharmaceuticals Corp
TickerABUS
CIK #0001447028
CUSIP03879J100
SectorLife Sciences - Pharmaceutical Preparations
Address100-8900 Glenlyon Parkway, Burnaby, BC V5J 5J8
Source [EDGAR]
CIK Filing 2011 - 2025
[0001447028] 10-K
[0001447028] 10-Q
[0001447028] 3
[0001447028] 4
[0001447028] 6-K
[0001447028] 8-K
[0001447028] D
[0001447028] SC 13D
[0001447028] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Two SEAS Capital LP Arbutus Biopharma Corp [2025-08-13] 0.0
Morgan Stanley Arbutus Biopharma Corp [2024-06-10] 10.3
Whitefort Capital Management LP Arbutus Biopharma Corp [2024-05-09] 6.8
Two SEAS Capital LP Arbutus Biopharma Corp [2023-11-21] 5.7
Whitefort Capital Management LP Arbutus Biopharma Corp [2023-09-11] 6.0
BlackRock Inc Arbutus Biopharma Corp [2023-02-03] 5.6
Morgan Stanley Arbutus Biopharma Corp [2020-07-16] 5.1
Foresite Capital Fund IV LP Arbutus Biopharma Corp [2019-12-09] 5.6
PRIMECAP Management Co/CA/ Arbutus Biopharma Corp [2019-11-05] 1.06
EcoR1 Capital LLC Arbutus Biopharma Corp [2019-02-14] 5.9
SVF Investments UK Ltd Arbutus Biopharma Corp [2017-09-15] 11.0
RTW Investments LP Arbutus Biopharma Corp [2017-05-17] 5.0
Machado Patrick Arbutus Biopharma Corp [2016-10-19] 29.2
QVT Financial LP Arbutus Biopharma Corp [2016-07-14] 29.3
Viking Global Investors LP Arbutus Biopharma Corp [2016-07-13] 29.3
Dexxon Holdings Ltd Arbutus Biopharma Corp [2016-07-13] 29.3
Lo Andrew Arbutus Biopharma Corp [2016-07-13] 29.3
PRIMECAP Management Co/CA/ Arbutus Biopharma Corp [2015-09-10] 5.18
Dexxon Holdings Ltd Tekmira Pharmaceuticals Corp [2015-03-16] 34.4
Roivant Sciences Ltd Tekmira Pharmaceuticals Corp [2015-03-16] 34.4
QVT Financial LP Tekmira Pharmaceuticals Corp [2015-03-16] 34.4
Franklin Resources Inc Tekmira Pharmaceuticals Corp [2015-02-10] 7.3
Falcon Edge Capital LP Tekmira Pharmaceuticals Corp [2015-01-22] 0.9
RA Capital Management LLC Tekmira Pharmaceuticals Corp [2015-01-20] 0.9
Franklin Resources Inc Tekmira Pharmaceuticals Corp [2014-01-10] 10.6
Newby Steven T Tekmira Pharmaceuticals Corp [2013-08-16] 0.0
BMO Financial Corp Tekmira Pharmaceuticals Corp [2013-01-10] 0.0
BMO Financial Corp Tekmira Pharmaceuticals Corp [2012-01-17] 0.0
Form 3/4/5 Filer 2011 - 2025
Sawhney Roger
Arbutus Biopharma Corp
Nguyen Tuan
Hasija Anuj
Androski Lindsay
Beardsley Robert A
Bishop Joseph E
Gline Matthew
Sims Karen
Hastings David C
McElhaugh Michael J.
Naftzger J. Christopher
Manchester Keith S
Rewolinski Melissa
Henriques Richard C Jr
Burgess Daniel D
Torti Frank
Meyers James R
Sofia Michael J.
Collier William H.
Howard Elizabeth
Tran Tram
Picchio Gaston
Roivant Sciences Ltd.
Cheng Andrew
Venker Eric
Potter Myrtle S
Lo Andrew
Machado Patrick
SoftBank Vision Fund L.P.
SVF GP (Jersey) Ltd
SVF Investments (UK) Ltd
SVF Holdings (UK) LLP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Halvorsen Ole Andreas
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Equities Master Ltd.
Viking Global Equities LP
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
Viking Global Performance LLC
Viking Global Equities II LP
VGE III Portfolio Ltd.
QVT Fund V LP
QVT Associates GP LLC
Oren Dan
Dexcel Pharma Technologies Ltd.
Dexxon Holdings Ltd.
Murray Mark J.
VandenEnden Koert
Ramaswamy Vivek
Conrad Herbert J
Symonds William T.
Lutwyche Peter
Cousins Bruce
Karbe Frank
Abrams Michael J.
Kowalski Mark
Sundheim Daniel S.
Higgins Patrick T.
Jewell Donald Gordon
Phillips Peggy V
Gardiner Diane
Brennan Paul A.
Kisner Daniel L
Form 13F Holdings
Firm Period DFND Voting Shares
Morgan Stanley [2025-06-30] DFND 24,141,380 24,162,383
Whitefort Capital Management LP [2025-06-30] SOLE 13,343,228 13,343,228
BlackRock, Inc. [2025-06-30] SOLE 12,536,212 12,869,286
Two SEAS Capital LP [2025-06-30] SOLE 10,443,317 10,443,317
Vanguard Group Inc [2025-06-30] SOLE 0 8,765,734
State Street Corp [2025-06-30] DFND 4,229,334 4,459,762
Geode Capital Management LLC [2025-06-30] DFND 3,637,021 3,637,021
Goldman Sachs Group Inc [2025-06-30] DFND 3,039,783 3,039,783
Adar1 Capital Management LLC [2025-06-30] SOLE 2,825,773 2,825,773
Blackbarn Capital Partners LP [2025-06-30] SOLE 2,603,521 2,603,521
Adage Capital Partners GP LLC [2025-06-30] SOLE 2,575,941 2,575,941
Foursixthree Capital LP [2025-06-30] SOLE 2,557,367 2,557,367
Woodline Partners LP [2025-06-30] SOLE 2,497,984 2,497,984
Rubric Capital Management LP [2025-06-30] SOLE 1,575,376 1,575,376
Osaic Holdings Inc [2025-06-30] DFND 0 1,348,416
Northern Trust Corp [2025-06-30] DFND 1,261,480 1,261,480
Saba Capital Management LP [2025-06-30] SOLE 1,260,129 1,260,129
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,253,829 1,253,829
FourWorld Capital Management LLC [2025-06-30] SOLE 1,226,710 1,226,710
Bank of America Corp /DE/ [2025-06-30] DFND 15,187 1,197,655
Aberdeen Group plc [2025-06-30] DFND 982,527 982,527
Hudson Bay Capital Management LP [2025-06-30] SOLE 965,000 965,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 800,028 932,302
Citigroup Inc [2025-06-30] DFND 884,614 884,614
Rangeley Capital LLC [2025-06-30] SOLE 865,000 865,000
Bank of Montreal /Can/ [2025-06-30] DFND 600,430 600,430
Wellington Management Group LLP [2025-06-30] DFND 0 531,551
Susquehanna International Group LLP [2025-06-30] OTR 219,428 507,628
Millennium Management LLC [2025-06-30] SOLE 499,483 499,483
Quinn Opportunity Partners LLC [2025-06-30] SOLE 250,702 464,513
Prev | Page 12 | Next
Terms | Privacy | Guide
tony@aum13f.com